↓ Skip to main content

Cochrane Database of Systematic Reviews

Dopamine agents for hepatic encephalopathy

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
peer_reviews
1 peer review site

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
106 Mendeley
citeulike
1 CiteULike
Title
Dopamine agents for hepatic encephalopathy
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd003047.pub3
Pubmed ID
Authors

Anders Ellekær Junker, Bodil Als‐Nielsen, Christian Gluud, Lise Lotte Gluud

Abstract

Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 15%
Student > Bachelor 16 15%
Student > Ph. D. Student 13 12%
Other 8 8%
Researcher 5 5%
Other 16 15%
Unknown 32 30%
Readers by discipline Count As %
Medicine and Dentistry 39 37%
Psychology 7 7%
Nursing and Health Professions 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Computer Science 2 2%
Other 11 10%
Unknown 38 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2020.
All research outputs
#16,106,935
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,216
of 11,842 outputs
Outputs of similar age
#189,655
of 328,150 outputs
Outputs of similar age from Cochrane database of systematic reviews
#190
of 214 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,150 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 214 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.